NEW YORK (GenomeWeb News) – Prodesse announced after the close of the market Thursday that the US Food and Drug Administration has cleared for marketing the firm's ProGastro Cd Assay.

The real-time PCR assay detects toxigenic strains of Clostridium difficile, a healthcare-associated infection that affects around 500,000 patients in the US annually. The test provides results in as little as three hours, said Prodesse.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.

Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."

Ivan Oransky discusses the need for reproducibility research at The Conversation.

The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.